| |
| |
|
| Insider
Information: |
Granadillo Pedro P |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
258,751 |
|
|
Indirect Shares
|
118,154 |
|
|
| Direct
Value |
$83,547,307 |
|
|
|
Indirect Value
|
$75,688,512 |
|
|
| Total
Shares |
376,905 |
|
|
| Total
Value |
$159,235,820 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
First Indiana Corp |
FINB |
Director |
2008-01-02 |
0 |
2004-01-02 |
0 |
Premium* |
|
|
Haemonetics Corp |
HAE |
Director |
2018-11-08 |
15,335 |
2005-09-02 |
0 |
Premium* |
|
|
Capricor Therapeutics |
CAPR |
Director |
2007-10-16 |
27,588 |
|
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Senior Vice President |
2004-09-23 |
106,316 |
2004-09-23 |
98,154 |
Premium* |
|
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
87,251 |
2009-10-07 |
0 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2013-02-07 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Director |
|
0 |
2019-05-09 |
20,000 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2007-10-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,588 |
|
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2009-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,994 |
4,994 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2010-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
8,744 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Board of Director |
– • – |
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
12,251 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
37,251 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
62,251 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
87,251 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior Vice President |
• – – |
2003-06-19 |
5 |
GD |
$0.00 |
$0 |
D/D |
123 |
96,706 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior Vice President |
• – – |
2003-07-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
75 |
96,631 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior Vice President |
• – – |
2003-11-05 |
5 |
GD |
$0.00 |
$0 |
D/D |
71 |
96,560 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior Vice President |
• – – |
2003-11-12 |
5 |
GD |
$0.00 |
$0 |
D/D |
1 |
96,559 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior Vice President |
• – – |
2004-09-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
16 |
106,395 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior Vice President |
• – – |
2004-09-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
79 |
106,316 |
0 |
- |
|
| FINB |
First Indiana Corp |
Director |
– • – |
2004-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
600 |
2,326 |
|
- |
|
| FINB |
First Indiana Corp |
Director |
– • – |
2005-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
600 |
3,083 |
|
- |
|
| FINB |
First Indiana Corp |
Director |
– • – |
2005-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
813 |
4,038 |
|
- |
|
| FINB |
First Indiana Corp |
officerTitle |
– • – |
2006-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
568 |
4,626 |
|
- |
|
| FINB |
First Indiana Corp |
Director |
– • – |
2007-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
807 |
6,653 |
0 |
- |
|
| FINB |
First Indiana Corp |
Director |
– • – |
2008-01-02 |
4 |
D |
$32.00 |
$220,306 |
D/D |
(6,885) |
0 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2005-09-02 |
4 |
B |
$44.69 |
$44,722 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2005-11-02 |
4 |
B |
$48.86 |
$146,588 |
D/D |
3,000 |
4,000 |
2.39 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2007-08-01 |
4 |
A |
$0.01 |
$3 |
D/D |
287 |
4,287 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2008-05-05 |
4 |
B |
$53.59 |
$96,462 |
D/D |
1,800 |
6,087 |
2.39 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2008-07-31 |
4 |
A |
$0.01 |
$4 |
D/D |
354 |
6,441 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2008-11-05 |
4 |
B |
$57.95 |
$202,829 |
D/D |
3,500 |
9,941 |
2.39 |
- |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
